Mono-allelic expression of the IGF-I receptor does not affect IGF responses in human fibroblasts

European Journal of Endocrinology

Volumn 151, Issue 4, 2004, Pages 521-529

  Hammer, Elke ^a   Kutsche, Kerstin ^a   Haag, Friedrich ^a   Ullrich, Kurt ^a   Sudbrak, Ralf ^b   Willig, Rolf Peter ^a   Braulke, Thomas ^a   Kübler, Bernd ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 2 METHYLAMINOPROPIONIC ACID; CARBON 14; GROWTH HORMONE; IODINE 125; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ALLELE; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CELL STIMULATION; CELL TRANSPORT; CHROMOSOME 15Q; CHROMOSOME ARM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOSS; GROWTH HORMONE BLOOD LEVEL; GROWTH REGULATION; GROWTH RETARDATION; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; POSTNATAL GROWTH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; SHORT STATURE;

BODY HEIGHT; CELL CULTURE TECHNIQUES; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; FIBROBLASTS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; RECEPTOR, IGF TYPE 1;

EID: 7244247057     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510521     Document Type: Article

References (40)

1. Kant SG, Wit JM & Breuning MH. Genetic analysis of short stature. Hormone Research 2003 60 157-165.
2. Le Roith D, Bondy C, Yakar S, Liu JL & Butler A. The somatomedin hypothesis: 2001. Endocrine Reviews 2001 53-74.
3. Jones JI & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 3-34.
4. LeRoith D, Werner H, Beitner-Johnson D & Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Reviews 1995 16 143-163.
5. Maile LA & Holly JM. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Hormone and IGF Research 1999 9 85-95.
6. Firth SM & Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocrine Reviews 2002 23 824-854.
7. Liu JP, Baker J, Perkins AS, Robertson EJ & Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf1) and type 1 IGF receptor (Igf1r). Cell 1993 75 59-72.
8. DeChiara TM, Efstratiadis A & Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990 345 78-80.
9. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N & Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes and Development 1993 7 2609-2617.
10. Woods KA, Camacho-Hubner C, Savage MO & Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 1996 335 1363-1367.
11. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ & Chernausek SD. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. New England Journal of Medicine 2003 349 2211-2222.
12. Pasquali F, Zuffardi O, Severi F, Colombo A & Burgio GR. Tandem translocation 15-13. Annales de Génétique 1973 16 47-50.
13. Fryns JP, de Muelenaere A & van den Berghe H. Interstitial deletion of the long arm of chromosome 15. Annales de Gé nétique 1982 25 59-60.
14. Clark RD. Del(15)(q22q24) syndrome with potter sequence. American Journal of Medical Genetics 1984 19 703-705.
15. Kristoffersson U, Heim S, Mandahl N, Sundkvist L, Szelest J & Hagerstrand I. Monosomy and trisomy of 15q24--qter in a family with a translocation t(6;15)(p25;q24). Clinical Genetics 1987 32 169-171.
16. Formiga LD, Poenaru L, Couronne F, Flori E, Eibel JL, Deminatti MM, Savary JB, Lai JL, Gilgenkrantz S & Pierson M. Interstitial deletion of chromosome 15: two cases. Human Genetics 1988 80 401-404.
17. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chretien M & Butler MG. An infant with deletion of the distal long arm of chromosome 15 (q26.1--qter) and loss of insulin-like growth factor 1 receptor gone. American Journal of Medical Genetics 1991 38 74-79.
18. Siebler T, Lopaczynski W, Terry CL, Casella SJ, Munson P, De Leon DD, Phang L, Blakemore KJ, McEvoy RC, Kelley RI & Nissley P. Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. Journal of Clinical Endocrinology and Metabolism 1995 80 3447-3457.
19. Rogan PK, Seip JR, Driscoll DJ, Papenhausen PR, Johnson VP, Raskin S, Woodward AL & Butler MG. Distinct 15q genotypes in Russelt-Silver and ring 15 syndromes. American Journal of Medical Genetics 1996 62 10-15.
20. Tönnies H, Schulze I, Hennsies H, Neumann LM, Keitzer R & Neitzel H. De novo terminal deletion of chromosome 15q26.1 characterised by comparative genomic hybridisation and FISH with locus specific probes. Journal of Medical Genetics 2001 38 617-621.
21. Nagai T, Shimokawa O, Harada N, Sakazume S, Ohashi H, Matsumoto N, Obata K, Yoshino A, Murakami N, Murai T, Sakuta R & Niikawa N. Postnatal overgrowth by 15q-trisomy and intrauterine growth retardation by 15q-monosomy due to familial translocation t(13;15): dosage effect of IGF1P? American Journal of Medical Genetics 2002 113 173-177.
22. Fukushima K, Komatsu H, Matsumoto M, Kobayashi H, Tsukimori K, Satoh S & Nakano H. IGF-related proteins at birth in a case of antenatally diagnosed silver-russell syndrome. Pediatric Research 2002 51 323-327.
23. Okubo Y, Siddle K, Firth H, O'Rahilly S, Wilson LC, Willatt L, Fukushima T, Takahashi S, Petry CJ, Saukkonen T, Stanhope R & Dunger DB. Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. Journal of Clinical Endocrinology and Metabolism 2003 88 5981-5988.
24. de Lacerda L, Carvalho JA, Stannard B, Werner H, Boguszewski MC, Sandrini R, Malozowski SN, Leroith D & Underwood LE. In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene. Clinical Endocrinology 1999 51 541-550.
25. Parker KC & Strominger JL. Localization of the sites of iodination of human beta 2-microglobulin: quaternary structure implications for histocompatibility antigens. Biochemistry 1983 22 1145-1153.
26. Braulke T, Götz W & Claussen M. Immunohistochemical localization of insulin-like growth factor binding protein-1, -3 and -4 in human fetal tissues and their analysis in media from fetal tissue explants. Growth Regulation 1996 6 55-65.
27. Körner C, Nürnberg B, Uhde M & Braulke T. Mannose 6-phosphate/insulin-like growth factor II receptor falls to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. Journal of Biological Chemistry 1995 270 287-295.
28. Kübler B, Draeger C, John H, Andag U, Scharf JG, Forssmann WG, Braulke T & Ständker L. Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3. FEBS Letters 2002 518 124-128.
29. Clemmons D, Dehoff M, Busby W Bayne M & Cascieri M. Competition for binding to insulin-like growth factor (IGF) binding protein-2, -3, -4, and -5 by the IGFs and IGF analogs. Endocrinology 1992 131 890-895.
30. Francis G, Aplin S, Milner S, McNeil K, Ballard F & Wallace J. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Biochemical Journal 1993 293 713-719.
31. Ferry R Jr, Katz L, Grimberg A, Cohen P & Weinzimer S. Cellular actions of insulin-like growth factor binding proteins. Hormone and Metabolic Research 1999 31 192-202.
32. Tollefsen S, Heath-Monnig E, Cascieri M, Bayne M & Daughaday W. Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-I resistance in cultured fibroblasts from a patient with short stature. Journal of Clinical Investigation 1991 87 1241-1250.
33. Roebroek A, Umans L, Pauli I, Robertson E, van Leuven F, Van de Ven W & Constam D. Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase furin. Development 1998 125 4863-4876.
34. Lehmann M, Andre F, Bellan C, Remacle-Bonnet M, Garrouste F, Parat F, Lissitsky J, Marvaldi J & Pommier G. Deficient processing and activity of type I insulin-like growth factor receptor in the furin-deficient LoVo-C5 cells. Endocrinology 1998 139 3763-3771.
35. Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V & Lopez-Otin C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene 2002 283 49-62.
36. Shi Z, Xu F, Loechel F, Wewer UM & Murphy LJ. ADAM 12, a disintegrin metalloproteinase, interacts with insulin-like growth factor-binding protein-3. Journal of Biological Chemistry 2000 275 18574-18580.
37. Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H & Baylink DJ. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 2002 41 15394-15403.
38. Barreca A, Bozzola M, Cesarone A, Steenbergh P, Holthuizen P, Severi F, Giordano G & Minuto F. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy. Journal of Clinical Endocrinology and Metabolism 1998 83 3534-3541.
39. Cox G, McDermott M, Merkel E, Stroh C, Ko S, Squires C, Gleason T & Russell D. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994 135 1913-1920.
40. Rajkumar K, Barron D, Lewitt M & Murphy L. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995 136 4029-4034.